Think Bioscience
Uses synthetic biology to develop small-molecule drugs for undruggable targets.
Company facts
- Founded
- 2019
- Employees
- 30
- Headquarters
- United States
- Type
- Private
- Funding
- Series A · $55M · 2026
Uses synthetic biology to develop small-molecule drugs for undruggable targets.
Company facts